Overexpression of S100P is an early marker of pancreatic cancer, which down-regulates the levels of cytoskeletal proteins, which disrupts the actin cytoskeleton network and changes in the phosphorylation status of cofilin. Here, S100P is linked to familial pancreatic carcinoma.